Commercial Helicopter Market Analysis, Size, Research and Economic Growth Report by 2033

 The global commercial helicopter market was valued at USD 6,782.6 million in 2024 and is projected to reach USD 9,945.5 million by 2033, expanding at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2033. This growth is primarily driven by several critical factors, including the rising demand for emergency medical services (EMS), expanding offshore oil and gas exploration activities, and increasing levels of urbanization across developed and emerging economies. Commercial helicopters are playing an increasingly important role in various critical and civil applications. These include Search and Rescue (SAR) operations, EMS transport, law enforcement, public safety enforcement, and aerial firefighting. The unique capability of helicopters to access hard-to-reach, remote, or rugged terrains quickly and efficiently makes them vital for missions requiring speed and precision. As a result, these applications are expected to significantly contribute to the continu...

Ursodeoxycholic Acid Market 2022 Share, Growth, Region Wise Analysis of Top Players, Application, Driver, Existing Trends


27 Jun 2019 - Global Ursodeoxycholic Acid Market is anticipated to grow at a CAGR of 7% in the forecast period owing to the developments occurring worldwide and changing demand from patients. Ursodeoxycholic acid is a steroid bile acid used for treating liver disorder. It naturally occurs in form of bile acid and is used to liquefy gallstones, which are rich in cholesterol. It also helps in improving the bile flow in primary biliary cirrhosis.

          

Ursodeoxycholic acid dissolves the cholesterol rich gallstones that accumulate due to cholesterol deposit. The acid helps prevent gallstone formation in patients’ body. Hence, people suffering from this disorder are driving the ursodeoxycholic acid market. Ursodeoxycholic acid also cures primary biliary cirrhosis by treating the symptoms. It slows down the spreading of the liver disorder and the bile duct.


Ursodeoxycholic acid also treats liver related symptom of cystic fibrosis, which is mostly present in children of 6-18 years of age. However, few symptoms may hamper the growth of ursodeoxycholic acid market. These symptoms comprise headache, diarrhea, hair loss, indigestion, vomiting or nausea, backache, unusual bleeding or bruising, cloudy and bloody urine, fever and cough, tarry or black stools, painful and/or frequent urination, swelling of lips, eyelids, tongue and face.

The market is categorized on the basis of product type, applications, and geography. On the basis of product type, market is divided into synthetic ursodeoxycholic acid and extraction ursodeoxycholic acid. Based on applications, market is divided into pharmacy and health products.

Geographically, market is segmented as North America, Europe, Asia Pacific, and RoW (Rest of the World). Asia Pacific is expected to hold the largest share of ursodeoxycholic acid market owing to the rise in liver diseases and rising elderly population in the region.

The key players in ursodeoxycholic acid market include ICE, Mitsubishi Tanabe Pharma, Arcelor Chemicals, Daewoong Chemical, Erregierre, Dipharma Francis, PharmaZell GmbH, Suzhou Tianlu, Grindeks, Abil Chempharma, Biotavia Labs, and Zhangshanbelling.

Market Segment:

Key Products

• Cholic Acid-based
• Chenodeoxycholic Acid-based

Key Regions

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Key Vendors

• Daewoong Bio
• Dipharma
• ICE
• PharmaZell
• Suzhou Tianlu
• Zhongshan Belling
• request free sample to get a complete list of companies



Comments

Popular posts from this blog

Thermoplastic Powder Coating Market Business Overview, Production, Consumption, By Players, Forecast To 2022

Digital Workplace Market Growth Analysis, Trends Forecast by Regions and Types to 2030

Cloud Computing Industry Research Report 2030 by Key Growth Drivers, Leading Players Review